Table 2.
Performance metrics for KNN, SVM, MLP and ensemble classifiers for five cancer types
| Classifier | Cancer class | Precision | Recall | F1-score |
|---|---|---|---|---|
| (a) Performance metrics for KNN | ||||
| KNN | High-grade serous ovarian cancer | 0.56 | 0.61 | 0.59 |
| Human diffuse type gastric cancer | 0.88 | 0.71 | 0.79 | |
| Intrahepatic cholangiocarcinoma | 0.79 | 0.85 | 0.82 | |
| Non BRCA1/BRCA2 familial breast cancer | 0.82 | 0.96 | 0.89 | |
| Pancreatic adenocarcinoma | 0.60 | 0.62 | 0.61 | |
| Weighted accuracy | 0.77 | |||
| (b) Performance metrics for SVM | ||||
| SVM | High-grade serous ovarian cancer | 0.66 | 0.58 | 0.62 |
| Human diffuse type gastric cancer | 0.83 | 0.66 | 0.73 | |
| Intrahepatic cholangiocarcinoma | 0.85 | 0.86 | 0.86 | |
| Non BRCA1/BRCA2 familial breast cancer | 0.84 | 0.99 | 0.91 | |
| Pancreatic adenocarcinoma | 0.62 | 0.71 | 0.66 | |
| Weighted accuracy | 0.76 | |||
| (c) Performance metrics for neural networks | ||||
| Neural networks | High-grade serous ovarian cancer | 0.75 | 0.74 | 0.74 |
| Human diffuse type gastric cancer | 0.83 | 0.78 | 0.80 | |
| Intrahepatic cholangiocarcinoma | 0.85 | 0.89 | 0.87 | |
| Non BRCA1/BRCA2 familial breast cancer | 0.89 | 0.92 | 0.91 | |
| Pancreatic adenocarcinoma | 0.78 | 0.78 | 0.78 | |
| Weighted accuracy | 0.82 | |||
| (d) Performance metrics for ensemble model | ||||
| Ensemble model | High-grade serous ovarian cancer | 0.76 | 0.78 | 0.77 |
| Human diffuse type gastric cancer | 0.82 | 0.77 | 0.79 | |
| Intrahepatic cholangiocarcinoma | 0.84 | 0.91 | 0.87 | |
| Non BRCA1/BRCA2 familial breast cancer | 0.89 | 0.93 | 0.91 | |
| Pancreatic adenocarcinoma | 0.83 | 0.77 | 0.80 | |
| Weighted accuracy | 0.82 | |||